Oral GnRH antagonists like Myfembree, Yselty, and Oriahnn now lead uterine fibroid treatment, offering high efficacy in ...

As Robert F. Kennedy Jr. signals a fat-friendlier approach to dietary guidelines, a new review offers fodder for opposing ...

Kyverna Therapeutics, Inc. shares surged on strong Phase 2 KYSA-8 data for Miv-cel in stiff person syndrome. Read why KYTX ...

A preliminary analysis of recurrence rates by two methods to estimate the reduction in recurrence rate shows an approximately 80% reduction in recurrence rate in the fully enrolled, 250 patient ...

Explore how the future of obesity drugs starts in preclinical discovery, addressing global challenges and advancing treatment options.

The global computer vision in healthcare market is projected to expand at a compound annual growth rate (CAGR) of approximately 25% over the forecast period. This robust growth is driven by the ...

A yearlong pattern of intense disruption followed by little improvement played out across nearly every major healthcare ...

We've made extraordinary progress. When I started my career, we were in analogue mode. We didn't have any ability to ...

Sanofi sees continued growth and strong financials despite a pipeline setback. Click for this updated look at SNY stock ...

This year, our scientists offered new hope for treating neurodegeneration and obesity and dramatically improved the odds that ...

Introduction Cognitive impairment is a common consequence after stroke. Intermittent theta burst stimulation (iTBS) has emerged as a promising cognitive therapy. However, traditional iTBS typically ...